Taysha Gene Therapies Inc
NASDAQ:TSHA

Watchlist Manager
Taysha Gene Therapies Inc Logo
Taysha Gene Therapies Inc
NASDAQ:TSHA
Watchlist
Price: 5.79 USD 0.52% Market Closed
Market Cap: 1.6B USD

Wall Street
Price Targets

TSHA Price Targets Summary
Taysha Gene Therapies Inc

Wall Street analysts forecast TSHA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TSHA is 10.78 USD with a low forecast of 5.05 USD and a high forecast of 19.95 USD.

Lowest
Price Target
5.05 USD
13% Downside
Average
Price Target
10.78 USD
86% Upside
Highest
Price Target
19.95 USD
245% Upside
Taysha Gene Therapies Inc Competitors:
Price Targets
AMGN
Amgen Inc
5% Upside
300601
Shenzhen Kangtai Biological Products Co Ltd
31% Upside
URGN
Urogen Pharma Ltd
65% Upside
DSGN
Design Therapeutics Inc
27% Upside
VRTX
Vertex Pharmaceuticals Inc
10% Upside
ALCLS
Cellectis SA
61% Upside
300653
Yantai Zhenghai Bio-Tech Co Ltd
25% Upside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
24% Upside

Revenue
Forecast

Revenue Estimate
Taysha Gene Therapies Inc

The compound annual growth rate of Taysha Gene Therapies Inc's revenue for the next 4 years is 109%.

N/A
Past Growth
109%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Taysha Gene Therapies Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Taysha Gene Therapies Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-79%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TSHA's stock price target?
Price Target
10.78 USD

According to Wall Street analysts, the average 1-year price target for TSHA is 10.78 USD with a low forecast of 5.05 USD and a high forecast of 19.95 USD.

What is Taysha Gene Therapies Inc's Revenue forecast?
Projected CAGR
109%

The compound annual growth rate of Taysha Gene Therapies Inc's revenue for the next 4 years is 109%.

Back to Top